{
  "id": 1786,
  "url": "https://nnemf.org/research/1786-glioma-incidence-and-survival-variations-by-county-level",
  "title": "Glioma incidence and survival variations by county-level socioeconomic measures",
  "authors": [],
  "journal": "",
  "year": "2019",
  "doi": "10.1002/cncr.32328",
  "pmid": null,
  "abstract": "Glioma incidence and survival variations by county-level socioeconomic measures Cote DJ, Ostrom QT, Gittleman H, Duncan KR, CreveCoeur T, Kruchko C, Smith TR, Stampfer MJ, Barnholtz-Sloan J. Glioma incidence and survival variations by county-level socioeconomic measures. Cancer. 2019 Jun 17. doi: 10.1002/cncr.32328. Abstract BACKGROUND: Multiple studies have reported higher rates of glioma in areas with higher socioeconomic status (SES) but to the authors' knowledge have not stratified by other factors, including race/ethnicity or urban versus rural location. METHODS: The authors identified the average annual age-adjusted incidence rates and calculated hazard ratios for death for gliomas of various subtypes, stratified by a county-level index for SES, race/ethnicity, US region, and rural versus urban status. RESULTS: Rates of glioma were highest in counties with higher SES (rate ratio, 1.18; 95% CI, 1.15-1.22 comparing the highest with the lowest quintiles [P < .001]). Stratified by race/ethnicity, higher rates in high SES counties persisted for white non-Hispanic individuals. Stratified by rural versus urban status, differences in incidence by SES were more pronounced among urban counties. Survival was higher for residents of high SES counties after adjustment for age and extent of surgical resection (hazard ratio, 0.82; 95% CI, 0.76-0.87 comparing the highest with the lowest quintile of SES [P < .001]). Survival was higher among white Hispanic, black, and Asian/Pacific Islander individuals compared with white non-Hispanic individuals, after adjustment for age, SES, and extent of surgical resection, and when restricted to those individuals with glioblastoma who received radiation and chemotherapy. CONCLUSIONS: The incidence of glioma was higher in US counties of high compared with low SES. These differences were most pronounced among white non-Hispanic individuals and white Hispanic individuals residing in urban areas. Better survival was observed in high SES counties, even when adjusting for extent of surgical resection, and when restricted to those who received radiation and chemotherapy for glioblastoma. Differences in incidence and survival were associated with SES and race, rather than rural versus urban status. Conflict of Interest Disclosures Quinn T. Ostrom was supported by a Research Training Grant from the Cancer Prevention and Research Institute of Texas (RP160097T). Meir J. Stampfer has served as a paid expert witness for Verizon (represented by the Alston Bird Law firm) in a lawsuit regarding the alleged link between cell phones and brain cancer for work performed outside of the current study. The law firm and company had no knowledge of or influence on the current study. The other authors made no disclosures. https://www.ncbi.nlm.nih.gov/pubmed/31206646",
  "effect": "unclear",
  "evidence": "moderate",
  "extraction": {
    "studyType": "cohort",
    "studyTypeLabel": "cohort",
    "effectDirection": "unclear",
    "evidenceLabel": "Moderate",
    "population": "US county residents with glioma (various subtypes), stratified by county-level socioeconomic status, race/ethnicity, US region, and rural vs urban status",
    "sampleSize": "—",
    "exposure": "",
    "confidencePct": "74",
    "peerReviewed": "yes",
    "mainFindings": "Glioma incidence rates were higher in counties with higher socioeconomic status (rate ratio 1.18, 95% CI 1.15-1.22 comparing highest vs lowest SES quintile; P<.001), with the higher incidence in high-SES counties persisting for white non-Hispanic individuals and being more pronounced in urban counties. Survival was higher for residents of high-SES counties after adjustment for age and extent of surgical resection (HR 0.82, 95% CI 0.76-0.87 comparing highest vs lowest SES quintile; P<.001).",
    "outcomes": [
      "Age-adjusted glioma incidence rate (rate ratios by SES quintile)",
      "Survival (hazard ratios for death)"
    ],
    "limitations": [],
    "keywords": [
      "glioma",
      "glioblastoma",
      "incidence",
      "survival",
      "socioeconomic status",
      "SES",
      "county-level",
      "race/ethnicity",
      "urban",
      "rural",
      "United States"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"cohort\",\n  \"exposure\": {\n    \"band\": null,\n    \"source\": null,\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": null\n  },\n  \"population\": \"US county residents with glioma (various subtypes), stratified by county-level socioeconomic status, race/ethnicity, US region, and rural vs urban status\",\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"Age-adjusted glioma incidence rate (rate ratios by SES quintile)\",\n    \"Survival (hazard ratios for death)\"\n  ],\n  \"main_findings\": \"Glioma incidence rates were higher in counties with higher socioeconomic status (rate ratio 1.18, 95% CI 1.15-1.22 comparing highest vs lowest SES quintile; P<.001), with the higher incidence in high-SES counties persisting for white non-Hispanic individuals and being more pronounced in urban counties. Survival was higher for residents of high-SES counties after adjustment for age and extent of surgical resection (HR 0.82, 95% CI 0.76-0.87 comparing highest vs lowest SES quintile; P<.001).\",\n  \"effect_direction\": \"unclear\",\n  \"limitations\": [],\n  \"evidence_strength\": \"moderate\",\n  \"confidence\": 0.74,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"glioma\",\n    \"glioblastoma\",\n    \"incidence\",\n    \"survival\",\n    \"socioeconomic status\",\n    \"SES\",\n    \"county-level\",\n    \"race/ethnicity\",\n    \"urban\",\n    \"rural\",\n    \"United States\"\n  ],\n  \"suggested_hubs\": []\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://www.ncbi.nlm.nih.gov/pubmed/31206646",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=1786",
  "updated": "2026-02-10 12:18:28"
}